Nucleotide Excision Repair is Elevated in Commercially Available Late Stage Breast Cancer Cell Lines as Compared to Early Stage Explants
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.
Part of the Pharmacy and Pharmaceutical Sciences Commons
Works by Omar Ibrahim in Pharmacy and Pharmaceutical Sciences
2019
Nucleotide Excision Repair in Acute Lymphoblastic Leukemia as a Predictor of Early Relapse
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.
2018
2016
NUCLEOTIDE EXCISION REPAIR (NER) IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AS APREDICTOR OF EARLY RELAPSE
Health Professions Division REACH Day
NUCLEOTIDE EXCISION REPAIR IS ELEVATED IN COMMERCIALLY AVAILABLE LATE STAGE
BREAST CANCER CELL LINES AS COMPARED TO EARLY STAGE EXPLANTS
Health Professions Division REACH Day